PURPOSE: The purpose of this study was to compare an Exercise Training Group (EX) with an Attention-Control Group (AT-C) to more specifically assess the impact of exercise training on individuals with heart failure (HF). METHODS:Forty-two individuals with HF were randomized to AT-C or EX that met with the same frequency and format of investigator interaction. Baseline, 12- and 24-week measurements of B-type naturetic peptide (BNP), 6-minute walk test (6-MWT), and the Kansas City Cardiomyopathy Questionnaire (KCCQ) were obtained. RESULTS:BNP tended to increase in the AT-C while remaining stable in the EX over time. A clinically significant increase in 6-MWT was demonstrated by the EX but not the AT-C. The EX achieved a clinically significant change on the KCCQ at 12 weeks, with further improvement by 24 weeks, while the AT-C demonstrated a clinically significant change at 24 weeks. CONCLUSIONS: Attention alone was inadequate to positively impact BNP levels or 6-MWT distances, but did have a positive impact on quality of life after 24 weeks. Although exercise offers enhanced benefits, individuals with HF unable to participate in an exercise program may still gain quality of life benefits from participation in a peer-support group that discusses topics pertinent to HF.
RCT Entities:
PURPOSE: The purpose of this study was to compare an Exercise Training Group (EX) with an Attention-Control Group (AT-C) to more specifically assess the impact of exercise training on individuals with heart failure (HF). METHODS: Forty-two individuals with HF were randomized to AT-C or EX that met with the same frequency and format of investigator interaction. Baseline, 12- and 24-week measurements of B-type naturetic peptide (BNP), 6-minute walk test (6-MWT), and the Kansas City Cardiomyopathy Questionnaire (KCCQ) were obtained. RESULTS:BNP tended to increase in the AT-C while remaining stable in the EX over time. A clinically significant increase in 6-MWT was demonstrated by the EX but not the AT-C. The EX achieved a clinically significant change on the KCCQ at 12 weeks, with further improvement by 24 weeks, while the AT-C demonstrated a clinically significant change at 24 weeks. CONCLUSIONS: Attention alone was inadequate to positively impact BNP levels or 6-MWT distances, but did have a positive impact on quality of life after 24 weeks. Although exercise offers enhanced benefits, individuals with HF unable to participate in an exercise program may still gain quality of life benefits from participation in a peer-support group that discusses topics pertinent to HF.
Authors: John Spertus; Eric Peterson; Mark W Conard; Paul A Heidenreich; Harlan M Krumholz; Philip Jones; Peter A McCullough; Ileana Pina; Joseph Tooley; William S Weintraub; John S Rumsfeld Journal: Am Heart J Date: 2005-10 Impact factor: 4.749
Authors: S P Buckelew; R Conway; J Parker; W E Deuser; J Read; T E Witty; J E Hewett; M Minor; J C Johnson; L Van Male; M J McIntosh; M Nigh; D R Kay Journal: Arthritis Care Res Date: 1998-06
Authors: Lee Ingle; Rhidian J Shelton; Alan S Rigby; Samantha Nabb; Andrew L Clark; John G F Cleland Journal: Eur Heart J Date: 2005-04-14 Impact factor: 29.983
Authors: B W Penninx; S P Messier; W J Rejeski; J D Williamson; M DiBari; C Cavazzini; W B Applegate; M Pahor Journal: Arch Intern Med Date: 2001-10-22
Authors: Stefan Krüger; Jürgen Graf; Dagmar Kunz; Tina Stickel; Peter Hanrath; Uwe Janssens Journal: J Am Coll Cardiol Date: 2002-08-21 Impact factor: 24.094
Authors: H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao Journal: Circulation Date: 1994-07 Impact factor: 29.690
Authors: Cheryl L Albright; Alana D Steffen; Lynne R Wilkens; Kami K White; Rachel Novotny; Claudio R Nigg; Kara Saiki; Wendy J Brown Journal: Prev Med Date: 2014-10-05 Impact factor: 4.018
Authors: Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2019-01-29
Authors: Birna Bjarnason-Wehrens; R Nebel; K Jensen; M Hackbusch; M Grilli; S Gielen; B Schwaab; B Rauch Journal: Eur J Prev Cardiol Date: 2019-06-08 Impact factor: 7.804
Authors: Hafiz M Imran; Muhammad Baig; Sebhat Erqou; Tracey H Taveira; Nishant R Shah; Alan Morrison; Gaurav Choudhary; Wen-Chih Wu Journal: J Am Heart Assoc Date: 2019-08-17 Impact factor: 5.501
Authors: Rod S Taylor; Viral A Sagar; Ed J Davies; Simon Briscoe; Andrew J S Coats; Hayes Dalal; Fiona Lough; Karen Rees; Sally Singh Journal: Cochrane Database Syst Rev Date: 2014-04-27
Authors: Viral A Sagar; Edward J Davies; Simon Briscoe; Andrew J S Coats; Hasnain M Dalal; Fiona Lough; Karen Rees; Sally Singh; Rod S Taylor Journal: Open Heart Date: 2015-01-28